Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis. - Fournier J; Boussat B; Dervaux B; Gaudin P; Romand X (Clinical and experimental rheumatology, 2025)